IL10 and myocardial infarction: It was further demonstrated that systemic administrations of mouse IL-10 (50 μg/kg, 5 times post-MI) in a mouse AMI model significantly reduced inflammatory responses, improved LV function, and mitigated cardiac remodeling (Krishnamurthy et al., 2009).